Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories develops, manufactures, and distributes life science research and clinical diagnostic products worldwide. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment offers instruments, systems, reagents, and consumables for separating, purifying, characterizing, and quantifying biological materials such as cells, proteins, and nucleic acids. These products are used in research, biopharmaceutical manufacturing, quality control, food safety, and science education. The Clinical Diagnostics segment provides diagnostic test systems, informatics systems, test kits, and quality controls for clinical, hospital, diagnostic reference, and transfusion laboratories. Customers include universities, medical schools, research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, and food producers.

Bio-Rad Laboratories is listed on the New York Stock Exchange (NYSE) under the ticker symbol BIO. The company trades in US dollars (USD), as it is headquartered in the United States. Being listed on the NYSE provides liquidity and access to a broad investor base. The stock is part of the Healthcare sector, specifically the Medical Devices industry, and is a well-known player in the life science and diagnostics markets.

Bio-Rad Laboratories operates in the Healthcare sector and is classified under the Medical Devices industry. This means the company focuses on developing and manufacturing products used in medical diagnostics and life science research. Its Medical Devices classification reflects its role in producing diagnostic test systems, instruments, and consumables for clinical and research laboratories. The company's products are essential for healthcare providers, researchers, and biopharmaceutical manufacturers, supporting applications from disease diagnosis to drug development.

Bio-Rad Laboratories is headquartered in Hercules, California, United States. Founded in 1952, the company serves a global market, including universities, medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its products are sold through a direct commercial organization as well as distributors, agents, brokers, and resellers worldwide. The company's geographic reach spans multiple regions, with a strong presence in the US and international markets.

Bio-Rad Laboratories generates revenue through two main segments: Life Science and Clinical Diagnostics. The Life Science segment sells instruments, systems, reagents, and consumables for biological material separation, purification, characterization, and quantification. These products are used in research, biopharmaceutical manufacturing, quality control, food safety, and education. The Clinical Diagnostics segment provides diagnostic test systems, informatics systems, test kits, and quality controls for clinical and hospital laboratories. The company earns money by selling these products directly and through distributors, agents, brokers, and resellers. Its customer base includes universities, research organizations, pharmaceutical companies, biotechnology firms, and clinical laboratories.